Modeling sleep data for a new drug in development using markov mixed-effects models.
about
Pharmacodynamic models for discrete data.Multinomial logistic functions in markov chain models of sleep architecture: internal and external validation and covariate analysis.A hidden Markov model to assess drug-induced sleep fragmentation in the telemetered rat.Relationship between zolpidem concentrations and sleep parameters in pediatric burn patients.Optimal clinical trial design based on a dichotomous Markov-chain mixed-effect sleep model.N-Heterocyclic Carbene Catalyzed [3+2] Cycloaddition of Enals with Masked Cinnamates for the Asymmetric One-Pot Synthesis of Adipic Acid Derivatives.Quantifying sleep architecture dynamics and individual differences using big data and Bayesian networks.
P2860
Q30578472-52B22FBB-EEB8-4318-A679-3F03F64C10B5Q35176909-C29515A2-1C44-473C-98A5-0997D3E2B79AQ39099181-FB1EAAE6-7D69-4F8A-A308-4FABB86E9A77Q41700212-F0E1A2A2-DC0A-4EFC-992C-1F7F378EE74FQ44643857-99988E43-4CB9-411C-ABA5-917B2C936B27Q48297100-56B72461-F631-4689-8DAD-968FC5E862A0Q52594115-2EB1CA17-2DD1-4F37-A060-39CA5421E701
P2860
Modeling sleep data for a new drug in development using markov mixed-effects models.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Modeling sleep data for a new drug in development using markov mixed-effects models.
@ast
Modeling sleep data for a new drug in development using markov mixed-effects models.
@en
type
label
Modeling sleep data for a new drug in development using markov mixed-effects models.
@ast
Modeling sleep data for a new drug in development using markov mixed-effects models.
@en
prefLabel
Modeling sleep data for a new drug in development using markov mixed-effects models.
@ast
Modeling sleep data for a new drug in development using markov mixed-effects models.
@en
P2093
P2860
P1476
Modeling sleep data for a new drug in development using markov mixed-effects models.
@en
P2093
Brian Corrigan
Daniele Ouellet
Maria C Kjellsson
Mats O Karlsson
P2860
P304
P356
10.1007/S11095-011-0490-X
P577
2011-06-17T00:00:00Z